European Journal of Pharmacology: Molecular Pharmacology
Volume 244, Issue 3, 15 February 1993, Pages 269-275
Regular paperDihydropyridine Ca2+ channel antagonists inhibit the salvage pathway for DNA synthesis in human vascular smooth muscle cells
References (32)
- et al.
Nifedipine increases cholesteryl ester hydrolytic activity in lipid-laden rabbit arterial smooth muscle cells
J. Clin. Invest.
(1985) - et al.
A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity
Anal. Biochem.
(1982) Comparative pharmacology of the nitrobenzylthioguanosine-sensitive and -resistant nucleoside transport mechanisms of Ehrlic ascites tumor cells
J. Pharmacol. Exp. Ther.
(1991)- et al.
Effects of angiotensin converting enzyme inhibition with cilazapril on intimal hyperplasia in injured arteries and vascular grafts in the baboon
Hypertension
(1991) - et al.
Smooth muscle cell migration induced by inflammatory cell products and its inhibition by a potent calcium antagonist, nilvadipine
Atherosclerosis
(1988) - et al.
Primary culture of human aortic intima cells as a model for testing antiatherosclerotic drugs: effects of cyclic AMP, prostaglandins, calcium antagonist, antioxidants, and lipid-lowering agents
Atherosclerosis
(1986) - et al.
Nucleoside and nucleobase transport in animal cells
Biochim. Biophys. Acta
(1988) - et al.
Platelet-derived growth factor and angiotensin II cause increases in cytosolic free calcium by different mechanisms in vascular smooth muscle cells
J. Cell. Physiol.
(1989) The pathogenesis of atherosclerosis: an update
New Engl. J. Med.
(1986)- et al.
Human red blood-cell Ca2+-antagonist binding sites: evidence for an unusual receptor coupled to the nucleoside transporter
Eur. J. Biochem.
(1985)
Membrane transport influences the rate of accumulation of cytosine arabinoside in human leukemia cells
J. Clin. Invest.
(1987)
Cytosine arabinoside influx and nucleoside transport sites in acute leukemia
J. Clin. Invest.
(1982)
In situ detection of TGF-α and EGF receptor mRNA in human atheromatous plaque tissue
Arteriosclerosis Thromb.
(1991)
Growth factor activity of endothelin on vascular smooth muscle
Am. J. Physiol.
(1990)
et al.Growth factor activity of endothelin on vascular smooth muscle
Cell Physiol.
(1990)
Ethylisopropylamiloride-sensitive pH control mechanisms modulate vascular smooth muscle cell growth
Am. J. Physiol.
(1991)
et al.Ethylisopropylamiloride-sensitive pH control mechanisms modulate vascular smooth muscle cell growth
Cell Physiol.
(1991)
Is epidermal growth factor present in human blood? Interference with the radioreceptor assay for epidermal growth factor
Biochem. Biophys. Res. Commun.
(1983)
Cited by (14)
Calcium channel antagonist verapamil inhibits neointimal formation and enhances apoptosis in a vascular graft model
2001, American Journal of SurgeryCitation Excerpt :In earlier studies, cell proliferation was measured by the uptake of [3H]-thymidine into DNA. The problem with this approach was revealed in later studies, which showed that calcium channel antagonists inhibit the uptake of [3H]-thymidine at the cellular level rather than inhibition of uptake into DNA [18,19]. New approaches using cell cycle specific antibodies have shown that calcium channel antagonists do not exert an inhibitory effect simply by decreasing [Ca2+]i, but that other more complex factors are probably involved [20].
Differential effects of Ca<sup>2+</sup> channel blockers on Ca<sup>2+</sup> transients and cell cycle progression in vascular smooth muscle cells
1998, European Journal of PharmacologyNitric oxide and the proliferation of vascular smooth muscle cells
1999, Cardiovascular ResearchEffects of verapamil on the proliferation, DNA synthesis and migration of human hepatoma cell line HepG2
2011, Journal of Sichuan University (Medical Science)
Copyright © 1993 Published by Elsevier B.V.